Abstract
Silver is a well known antimicrobial agent against a wide range of microorganisms – over 650 microorganisms from different classes, such as gram-positive and gram-negative bacteria, fungi or viruses. Due to the ratio between positive and negative (side) effects, silver gained advantages over many other antimicrobial agents, and especially antibiotics. The potential applications of silver nanoparticles (Ag-NPs) are strongly influenced by some factors such as size and shape. Besides the huge efforts in the field of synthesis, characterization and applications of Ag-NPs there are many unknown or contradictory observations/conclusions. The current review is focused on the synthesis and characterization of silver for biomedical applications and point out the correlations between the characteristics of Ag-NPs (size and shape, especially) and their induced effects.
Keywords: Silver nanoparticles, shape and size control, silver substituted hydroxyapatite, antimicrobial, antitumoral, antiviral.
Current Organic Chemistry
Title:Silver Based Materials for Biomedical Applications
Volume: 18 Issue: 2
Author(s): Ioan-Avram Nedelcu, Anton Ficai, Maria Sonmez, Denisa Ficai, Ovidiu Oprea and Ecaterina Andronescu
Affiliation:
Keywords: Silver nanoparticles, shape and size control, silver substituted hydroxyapatite, antimicrobial, antitumoral, antiviral.
Abstract: Silver is a well known antimicrobial agent against a wide range of microorganisms – over 650 microorganisms from different classes, such as gram-positive and gram-negative bacteria, fungi or viruses. Due to the ratio between positive and negative (side) effects, silver gained advantages over many other antimicrobial agents, and especially antibiotics. The potential applications of silver nanoparticles (Ag-NPs) are strongly influenced by some factors such as size and shape. Besides the huge efforts in the field of synthesis, characterization and applications of Ag-NPs there are many unknown or contradictory observations/conclusions. The current review is focused on the synthesis and characterization of silver for biomedical applications and point out the correlations between the characteristics of Ag-NPs (size and shape, especially) and their induced effects.
Export Options
About this article
Cite this article as:
Nedelcu Ioan-Avram, Ficai Anton, Sonmez Maria, Ficai Denisa, Oprea Ovidiu and Andronescu Ecaterina, Silver Based Materials for Biomedical Applications, Current Organic Chemistry 2014; 18 (2) . https://dx.doi.org/10.2174/13852728113176660141
DOI https://dx.doi.org/10.2174/13852728113176660141 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
p53 as the Focus of Gene Therapy: Past, Present and Future
Current Drug Targets Prostaglandins Pathway as a Possible Biological Link Between Cancer and Major Depression
Current Angiogenesis (Discontinued) Receptor-Specific Peptides for Targeting of Liposomal, Polymeric, and Dendrimeric Nanoparticles in Cancer Diagnosis and Therapy
Current Molecular Imaging (Discontinued) Kit: Molecule of Interest for the Diagnosis and Treatment of Mastocytosis and other Neoplastic Disorders
Current Cancer Drug Targets The Emerging Role of Unmetabolized Folic Acid in Human Diseases: Myth or Reality?
Current Drug Metabolism Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges
Current Nanomedicine Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
Current Drug Targets Pharmacogenetics and the Pharmaceutical Industry
Current Pharmaceutical Design Predictive Biomarkers to Tyrosine Kinase Inhibitors for the Epidermal Growth Factor Receptor in Non-Small-Cell Lung Cancer
Current Drug Targets Features Identification for Phenotypic Classification Based on Genes and Gene Pairs
Current Bioinformatics Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy
Current Medicinal Chemistry Interaction of Biologically Active Amines with Mitochondria and Their Role in the Mitochondrial-Mediated Pathway of Apoptosis
Current Medicinal Chemistry Folate Targeted Solid Lipid Nanoparticles of Simvastatin for Enhanced Cytotoxic Effects of Doxorubicin in Chronic Myeloid Leukemia
Current Nanoscience Large Granular Lymphocyte (LGL) Leukemia: Pathobiology, Diagnosis and Treatment
Current Cancer Therapy Reviews Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials The Genetic and Epigenetic Effects of 5-Azacytidine and its Major Breakdown Product Guanylurea
Epigenetic Diagnosis & Therapy (Discontinued) Chemotherapy of Chagas Disease
Current Pharmaceutical Design Exosomal microRNAs as Potentially Useful Tools in Cancer Biomarker Discovery
Recent Patents on Biomarkers Screening of Potential Plant Compounds as Survivin Inhibitors and its Anti-Cancer Efficacy by Molecular Docking
Current Enzyme Inhibition The Role of Exosomes and Exosome-derived microRNAs in Atherosclerosis
Current Pharmaceutical Design